Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.250
+0.040 (3.31%)
At close: Mar 6, 2026, 4:00 PM EST
1.260
+0.010 (0.77%)
After-hours: Mar 6, 2026, 7:59 PM EST
Dermata Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 4.48 | 4.31 | 3.97 | 4.02 | 4.4 | 1.57 | |
| Research & Development | 4.6 | 8.2 | 4.07 | 5.65 | 3.46 | 1.61 | |
| Operating Expenses | 9.07 | 12.51 | 8.04 | 9.67 | 7.86 | 3.17 | |
| Operating Income | -9.07 | -12.51 | -8.04 | -9.67 | -7.86 | -3.17 | |
| Interest Expense | - | - | - | - | -0.05 | -0.2 | |
| Interest & Investment Income | 0.23 | 0.23 | 0.25 | 0.06 | - | - | |
| EBT Excluding Unusual Items | -8.85 | -12.29 | -7.79 | -9.61 | -7.9 | -3.37 | |
| Other Unusual Items | - | - | - | - | - | 0.13 | |
| Pretax Income | -8.85 | -12.29 | -7.79 | -9.61 | -7.9 | -3.24 | |
| Net Income | -8.85 | -12.29 | -7.79 | -9.61 | -7.9 | -3.24 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 2.56 | - | |
| Net Income to Common | -8.85 | -12.29 | -7.79 | -9.61 | -10.46 | -3.24 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 871.92% | 684.78% | - | - | - | - | |
| EPS (Basic) | -12.13 | -80.32 | -399.87 | - | - | - | |
| EPS (Diluted) | -12.13 | -80.32 | -399.87 | - | - | - | |
| EBITDA | - | - | - | - | -7.86 | -3.17 | |
| D&A For EBITDA | - | - | - | - | 0 | 0 | |
| EBIT | -9.07 | -12.51 | -8.04 | -9.67 | -7.86 | -3.17 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.